Artesunate Inhibits Metastatic Potential in Cisplatin-Resistant Bladder Cancer Cells by Altering Integrins

Artesunate Inhibits Metastatic Potential in Cisplatin-Resistant Bladder Cancer Cells by Altering Integrins

The survival of patients with locally advanced and metastatic bladder cancer (BCa) is persistently low. Hence, new treatment options are urgently needed. Artesunate (ART) a derivative of artemisinin, used in Traditional Chinese Medicine, shows anti-tumor activity extending over a broad spectrum of h...

Full description

Saved in:
Bibliographic Details
Main Authors: Olesya Vakhrusheva, Fuguang Zhao, Sascha Dennis Markowitsch, Kimberly Sue Slade, Maximilian Peter Brandt, Igor Tsaur, Jindrich Cinatl, Martin Michaelis, Thomas Efferth, Roman Alexander Blaheta, Axel Haferkamp, Eva Juengel
Format: Article
Language:English
Published: MDPI AG 2025-04-01
Series:Cells
Subjects:
bladder cancer (BCa)
artesunate (ART)
cisplatin resistance
adhesion
chemotaxis
migration
Online Access:https://www.mdpi.com/2073-4409/14/8/570
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items